University of Tasmania
Browse

Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014

journal contribution
posted on 2023-05-19, 09:36 authored by Louise CooleyLouise Cooley, Dendle, C, Wolf, J, Teh, BW, Chen, SC, Boutlis, C, Thursky, KA
Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer-related immunosuppression. There are well-defined patients who are at risk of PJP due to the status of their underlying malignancy, treatment-related immunosuppression and/or concomitant use of corticosteroids. Prophylaxis is highly effective and should be given to all patients at moderate to high risk of PJP. Trimethoprim-sulfamethoxazole is the drug of choice for prophylaxis and treatment, although several alternative agents are available.

History

Publication title

Internal Medicine Journal

Volume

44

Issue

12

Pagination

1350-1363

ISSN

1444-0903

Department/School

Tasmanian School of Medicine

Publisher

Blackwell Science Asia

Place of publication

Australia

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC